SE8101065L - Antitrombinberedning - Google Patents
AntitrombinberedningInfo
- Publication number
- SE8101065L SE8101065L SE8101065A SE8101065A SE8101065L SE 8101065 L SE8101065 L SE 8101065L SE 8101065 A SE8101065 A SE 8101065A SE 8101065 A SE8101065 A SE 8101065A SE 8101065 L SE8101065 L SE 8101065L
- Authority
- SE
- Sweden
- Prior art keywords
- pct
- sec
- date
- antithrombin
- salts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/005—Enzyme inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0023—Heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
- A61L2/04—Heat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
- C07K14/8128—Antithrombin III
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP53000714A JPS597693B2 (ja) | 1978-01-07 | 1978-01-07 | 抗トロンビン製剤及びその製法 |
Publications (2)
Publication Number | Publication Date |
---|---|
SE8101065L true SE8101065L (sv) | 1981-02-17 |
SE459784B SE459784B (sv) | 1989-08-07 |
Family
ID=11481420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8101065A SE459784B (sv) | 1978-01-07 | 1981-02-17 | Stabiliserad torr antitrombinberedning |
Country Status (10)
Country | Link |
---|---|
US (1) | US4340589A (sv) |
JP (1) | JPS597693B2 (sv) |
BE (1) | BE877439A (sv) |
CA (1) | CA1126652A (sv) |
CH (1) | CH645537A5 (sv) |
FR (1) | FR2460138A1 (sv) |
GB (1) | GB2064545B (sv) |
NL (1) | NL181781C (sv) |
SE (1) | SE459784B (sv) |
WO (1) | WO1980002798A1 (sv) |
Families Citing this family (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2916711A1 (de) * | 1979-04-25 | 1980-11-06 | Behringwerke Ag | Blutgerinnungsfaktoren und verfahren zu ihrer herstellung |
EP0035204B2 (en) * | 1980-03-05 | 1991-05-22 | Miles Inc. | Pasteurized therapeutically active protein compositions |
US4363319A (en) * | 1980-06-30 | 1982-12-14 | Applied Medical Devices, Inc. | Ready-to-use bandage incorporating a coagulant composition and method of preparing same |
DE3170001D1 (en) * | 1980-09-30 | 1985-05-23 | Bayer Ag | Method for the production of an antithrombin-heparin complex and pharmaceutical compositions containing the complex |
DE3038163A1 (de) * | 1980-10-09 | 1982-05-06 | Boehringer Mannheim Gmbh, 6800 Mannheim | Thrombininhibitor, seine herstellung und verwendung |
JPS5967228A (ja) * | 1982-10-07 | 1984-04-16 | Green Cross Corp:The | 寒冷不溶性グロブリンの凍結乾燥方法 |
JPS6054287B2 (ja) * | 1983-10-19 | 1985-11-29 | 株式会社ミドリ十字 | 血漿蛋白の加熱処理方法 |
US4656254A (en) * | 1985-12-02 | 1987-04-07 | Miles Laboratories, Inc. | Method of preparing alpha-1-proteinase inhibitor and antithrombin III |
DE3624453A1 (de) * | 1986-07-19 | 1988-01-28 | Behringwerke Ag | Verfahren zur herstellung von humanem antithrombin iii (atiii), dafuer geeignete vektoren und wirtszellen, so erhaltenes, biologisch aktives atiii und dieses enthaltende arzneimittel |
DE3625090A1 (de) * | 1986-07-24 | 1988-01-28 | Behringwerke Ag | Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung |
US4894444A (en) * | 1987-07-16 | 1990-01-16 | Merck & Co., Inc. | Recovery and purification of immunogens from immunogen-alum complexes |
US4877608A (en) * | 1987-11-09 | 1989-10-31 | Rorer Pharmaceutical Corporation | Pharmaceutical plasma protein formulations in low ionic strength media |
CA1331133C (en) * | 1988-03-01 | 1994-08-02 | Michael Jon Pikal | Pharmaceutical growth hormone formulations |
CA1341379C (en) | 1988-04-28 | 2002-07-23 | Welfide Corporation | Purified antithrombin-iii and methods of producing the same |
WO1989011298A1 (en) * | 1988-05-27 | 1989-11-30 | Centocor, Inc. | Formulation for antibody reagents |
WO1989011297A1 (en) * | 1988-05-27 | 1989-11-30 | Centocor, Inc. | Freeze-dried formulation for antibody products |
US5252557A (en) * | 1988-07-25 | 1993-10-12 | Kiyoshi Kita | Administration method of antithrombin |
CA1336396C (en) * | 1988-07-25 | 1995-07-25 | Kiyoshi Kita | Intraocular anticoagulant including antithrombin iii and method of administration |
JPH0341033A (ja) * | 1989-07-07 | 1991-02-21 | Kyowa Hakko Kogyo Co Ltd | 安定なモチリン類含有製剤 |
US5591431A (en) * | 1990-03-09 | 1997-01-07 | G.D. Searle & Co. | Enhancement of clot lysis |
AT402367B (de) * | 1990-10-11 | 1997-04-25 | Immuno Ag | Pharmazeutische zubereitung auf basis von lys-plasminogen |
JP3494667B2 (ja) * | 1992-10-02 | 2004-02-09 | アベンティス ファーマ株式会社 | アンチトロンビンiii製剤 |
WO1994022471A1 (en) * | 1993-04-05 | 1994-10-13 | The Green Cross Corporation | Liquid antithrombin iii preparation and method of stabilizing the same |
EP0653212A4 (en) * | 1993-04-05 | 1997-08-20 | Green Cross Corp | ANTITHROMBIN III COMPOSITION IN LIQUID FORM AND METHOD FOR STABILIZING IT. |
US5397479A (en) * | 1993-04-26 | 1995-03-14 | International Remote Imaging Systems, Inc. | Composition and method for enrichment of white blood cells from whole human blood |
US7045585B2 (en) * | 1995-11-30 | 2006-05-16 | Hamilton Civic Hospital Research Development Inc. | Methods of coating a device using anti-thrombin heparin |
US6491965B1 (en) | 1995-11-30 | 2002-12-10 | Hamilton Civic Hospitals Research Development, Inc. | Medical device comprising glycosaminoglycan-antithrombin III/heparin cofactor II conjugates |
US6562781B1 (en) | 1995-11-30 | 2003-05-13 | Hamilton Civic Hospitals Research Development Inc. | Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates |
US5989593A (en) * | 1996-11-20 | 1999-11-23 | Yoshitomi Pharmaceutical Industries, Ltd. | Method for producing antithrombin-III, method for purifying it, and preparation containing it |
DE19856443A1 (de) * | 1998-12-08 | 2000-06-21 | Centeon Pharma Gmbh | Stabilisiertes Antithrombin III-Präparat |
SE9902388D0 (sv) * | 1999-06-23 | 1999-06-23 | Pharmacia & Upjohn Ab | Method for purification of proteins |
US6518406B1 (en) * | 1999-06-23 | 2003-02-11 | Octapharma Ag | Method for purification of proteins |
US20050048126A1 (en) * | 2000-12-22 | 2005-03-03 | Barrett Rabinow | Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug |
US20030072807A1 (en) * | 2000-12-22 | 2003-04-17 | Wong Joseph Chung-Tak | Solid particulate antifungal compositions for pharmaceutical use |
US8563693B2 (en) * | 2001-01-26 | 2013-10-22 | Acceleration Biopharmaceuticals, Inc. | Method of treating human immunodeficiency virus infection in a mammal comprising administering heparin-activated antithrombin III |
EP1362127B1 (en) * | 2001-01-26 | 2007-11-07 | The General Hospital Corporation | Serpin drugs for treatment of hiv infection and method of use thereof |
JP2005504090A (ja) | 2001-09-26 | 2005-02-10 | バクスター・インターナショナル・インコーポレイテッド | 分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製 |
US20040229778A1 (en) * | 2003-05-13 | 2004-11-18 | Elmaleh David R. | Pharmaceutical compositions of antithrombin III for the treatment of retroviral diseases |
US7498130B2 (en) | 2003-05-13 | 2009-03-03 | Massachusetts General Hospital | Method of reducing viral load |
ES2221817B1 (es) * | 2004-07-26 | 2005-10-01 | Probitas Pharma, S.A. | "soluciones de albumina humana terapeutica con baja actividad del activador de precalicreina (pka) y procedimiento de obtencion de las mismas". |
MX2007015183A (es) * | 2005-06-14 | 2008-02-19 | Baxter Int | Formulaciones farmaceuticas para minimizar las interacciones farmaco-farmaco. |
US8426467B2 (en) | 2007-05-22 | 2013-04-23 | Baxter International Inc. | Colored esmolol concentrate |
US8722736B2 (en) | 2007-05-22 | 2014-05-13 | Baxter International Inc. | Multi-dose concentrate esmolol with benzyl alcohol |
EP2236520A1 (en) * | 2009-03-31 | 2010-10-06 | Leukocare Ag | Stabilizing composition for immobilized biomolecules |
EP2496246B1 (en) | 2009-11-03 | 2018-06-27 | Grifols Therapeutics LLC | Composition, method, and kit for alpha-1 proteinase inhibitor |
PL2503995T3 (pl) * | 2009-11-24 | 2018-01-31 | Grifols Therapeutics Inc | Sposoby liofilizacji, kompozycje i zestawy |
EP2834635A4 (en) | 2012-04-03 | 2015-09-02 | Smiths Medical Asd Inc | COMPOSITIONS WITH A HEPARINE ACCUMULATIVE AND METHOD THEREFOR |
CN103041380B (zh) * | 2012-12-28 | 2014-08-06 | 中国医学科学院输血研究所 | 人抗凝血酶制剂干热处理过程中的稳定剂 |
CN102973526B (zh) * | 2012-12-28 | 2015-09-09 | 贵州泰邦生物制品有限公司 | 人抗凝血酶制剂冷冻干燥过程中的保护剂 |
DE112016007531T5 (de) * | 2016-12-21 | 2019-11-21 | Chung Chin SUN | Neues verfahren zum blutplasmaprotein-aktivitätserhalt |
CN111537326B (zh) * | 2020-05-07 | 2023-05-16 | 天津德祥生物技术股份有限公司 | 制备冻干血小板的方法及其应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA958339A (en) * | 1970-09-19 | 1974-11-26 | Yoshio Yoshimura | Stabilization of microorganism cells lytic enzyme |
SE392038B (sv) * | 1971-09-08 | 1977-03-14 | Kabi Ab | Forfarande for isolering av antitrombin ur blod eller blodprodukter |
JPS5029005B2 (sv) * | 1972-05-08 | 1975-09-19 | ||
JPS532931B2 (sv) * | 1973-12-05 | 1978-02-01 | ||
US4087415A (en) * | 1976-06-09 | 1978-05-02 | William L. Wilson | Antithrombin III |
JPS6040859B2 (ja) * | 1977-07-27 | 1985-09-12 | 喜温 三浦 | 抗血栓性人工医療材料 |
-
1978
- 1978-01-07 JP JP53000714A patent/JPS597693B2/ja not_active Expired
-
1979
- 1979-06-18 US US06/237,125 patent/US4340589A/en not_active Expired - Lifetime
- 1979-06-18 CH CH116681A patent/CH645537A5/de not_active IP Right Cessation
- 1979-06-18 WO PCT/JP1979/000154 patent/WO1980002798A1/ja unknown
- 1979-06-18 GB GB8103301A patent/GB2064545B/en not_active Expired
- 1979-06-29 CA CA330,934A patent/CA1126652A/en not_active Expired
- 1979-07-03 FR FR7917217A patent/FR2460138A1/fr active Granted
- 1979-07-03 BE BE0/196094A patent/BE877439A/xx not_active IP Right Cessation
- 1979-07-04 NL NLAANVRAGE7905220,A patent/NL181781C/xx not_active IP Right Cessation
-
1981
- 1981-02-17 SE SE8101065A patent/SE459784B/sv not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
GB2064545B (en) | 1983-03-09 |
WO1980002798A1 (en) | 1980-12-24 |
CA1126652A (en) | 1982-06-29 |
GB2064545A (en) | 1981-06-17 |
SE459784B (sv) | 1989-08-07 |
BE877439A (fr) | 1979-11-05 |
FR2460138B1 (sv) | 1982-10-08 |
NL181781C (nl) | 1987-11-02 |
FR2460138A1 (fr) | 1981-01-23 |
NL181781B (nl) | 1987-06-01 |
JPS5495715A (en) | 1979-07-28 |
NL7905220A (nl) | 1981-01-06 |
US4340589A (en) | 1982-07-20 |
CH645537A5 (en) | 1984-10-15 |
JPS597693B2 (ja) | 1984-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8101065L (sv) | Antitrombinberedning | |
DK369284A (da) | Aprotininhomologe med andre aminosyrer i stilling 15 i stedet for lysin, fremgangsmaade til fremstilling heraf samt deres anvendelse som laegemiddel | |
PT82841B (pt) | Processo para a preparacao de novos derivados de aminoacidos e de composicoes farmaceuticas que os contem | |
MX6015E (es) | Procedimiento para la preparacion de composiciones de globulina de suero inmune,altamente estabilizada | |
GB1524431A (en) | Production of long acting insulin preparations | |
ES2014309B3 (es) | Utilizacion de una sal para influenciar el vertido de composiciones espesas | |
FI822414L (fi) | Syror av n-substituerade 2-pyrrolidon-4-karboxylsyror som befuktningsmedel | |
ES2137162T3 (es) | Cefalosporinas y homologos, preparaciones y composiciones farmaceuticas. | |
SE7904118L (sv) | Sett att framstella en urokinaskomposition | |
DE69232205T2 (de) | Haarbehandlungszusammensetzung | |
FI810559L (fi) | Nya 3,4,5-trihydroxipiperidinderivat foerfaranden foer deras framstaellning och deras anvaendning som laekemedel samt i djurnaering | |
DE3867445D1 (de) | Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren. | |
PT90362A (pt) | Metodo para o tratamento de doencas muco-epiteliais e da pele em mamiferos que utiliza acidos 4-quinolinocarboxilicos e seus derivados e processo para a preparacao de composicoes farmaceuticas que contem os mesmos compostos | |
FI875353A (fi) | Cytostatiskt verkande antracyklinderivat. | |
SE7904742L (sv) | Stabiliserade mjolkproteinhaltiga kompositioner | |
SE8100005L (sv) | Vattenhaltiga kompositioner innehallande stabiliserade enzymer | |
DK160316C (da) | Analogifremgangsmaade til fremstilling af beta-casomorphinanaloge peptider samt pharmakologisk acceptable syreadditionssalte og metalkomplekser deraf | |
ATE152125T1 (de) | Neue synthetische isohirudine mit verbesserter stabilität | |
KR840002654A (ko) | 파모티딘의 주사용 조성물의 제조방법 | |
NO843204L (no) | Nye dihydropyridinforbindelser og herbicide preparater inneholdende disse som aktive bestanddeler | |
DK148903C (da) | Analogifremgangsmaade til fremstilling af enkephalin-analoge pentapeptidderivater eller syreadditionssalte deraf | |
NO178325C (no) | Fremgangsmåte for fremstilling av et t-PA injeksjonspreparat | |
SE7712985L (sv) | Fasta medel, vilka i vattenhaltiga system utvecklar antimikrobiell verksamhet | |
PT86944A (pt) | Verfahren zur isolierung von basalmembranproteinen aus menschlichen und tierischen geweben | |
DK161833C (da) | Analogifremgangsmaade til fremstilling af n-(vinblastinoyl-23)-derivater af aminosyrer eller farmaceutisk acceptable syreadditionssalte deraf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8101065-4 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 8101065-4 Format of ref document f/p: F |